Fig. 1From: Real-world study of the impact of recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) on quality of life and productivity in EuropeMean EQ-5D VAS scores for platinum-eligible patients with R/M SCCHN (A) and their caregivers (B) showing national population normsBack to article page